Literature DB >> 8100991

Effect of potassium channel modulators on the release of glutamate induced by ischaemic-like conditions in rat hippocampal slices.

S Zini1, M P Roisin, C Armengaud, Y Ben-Ari.   

Abstract

The effects of the potassium channel openers lemakalim, RP 52891 and galanin and the potassium channel blockers glibenclamide and gliquidone were evaluated by the release of endogenous glutamate from rat hippocampal slices subjected to a brief period of ischaemia (2-10 min). Ischaemia was mimicked by incubating slices in a glucose free medium equilibrated with 95% N2/5% CO2. These conditions evoked a release of glutamate which was insensitive to tetrodotoxin and Ca2+ indicating a non-vesicular origin. The release of glutamate evoked by a 6- or 8-min period of ischaemia was reduced by 25-40% in the presence of lemakalim (10 microM), RP 52891 (10 microM) or galanin (0.3 microM), whereas it was enhanced by 60 to 100% in the presence of glibenclamide (1 microM) and gliquidone (2 microM). These observations suggest that cellular damage resulting from ischaemia induced excessive release of glutamate in the hippocampus may be partly reduced by potassium channel openers, and conversely increased by sulfonylureas.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8100991     DOI: 10.1016/0304-3940(93)90322-c

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  15 in total

1.  Modulation of hippocampal excitability and seizures by galanin.

Authors:  A M Mazarati; J G Hohmann; A Bacon; H Liu; R Sankar; R A Steiner; D Wynick; C G Wasterlain
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

2.  Assessment of tissue viability following electroosmotic push-pull perfusion from organotypic hippocampal slice cultures.

Authors:  Amy E Rupert; Y Ou; M Sandberg; S G Weber
Journal:  ACS Chem Neurosci       Date:  2013-05-02       Impact factor: 4.418

3.  Electroosmotic push-pull perfusion: description and application to qualitative analysis of the hydrolysis of exogenous galanin in organotypic hippocampal slice cultures.

Authors:  Amy E Rupert; Y Ou; M Sandberg; S G Weber
Journal:  ACS Chem Neurosci       Date:  2013-04-30       Impact factor: 4.418

4.  Preclinical evaluation of intravenous NAX 810-2, a novel GalR2-preferring analog, for anticonvulsant efficacy and pharmacokinetics.

Authors:  Cameron S Metcalf; Brian D Klein; Daniel R McDougle; Liuyin Zhang; Dan Kaufmann; Grzegorz Bulaj; H Steve White
Journal:  Epilepsia       Date:  2017-01-18       Impact factor: 5.864

5.  Galanin modulation of seizures and seizure modulation of hippocampal galanin in animal models of status epilepticus.

Authors:  A M Mazarati; H Liu; U Soomets; R Sankar; D Shin; H Katsumori; U Langel; C G Wasterlain
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

6.  Effects of extracellular pH reductions on [(3)H]D-aspartate and [(3)H]noradrenaline release by presynaptic nerve terminals isolated from rat cerebral cortex.

Authors:  M D'Amico; I Samengo; Maria Martire
Journal:  J Neural Transm (Vienna)       Date:  2009-09-25       Impact factor: 3.575

7.  Patterns of seizures, hippocampal injury and neurogenesis in three models of status epilepticus in galanin receptor type 1 (GalR1) knockout mice.

Authors:  A Mazarati; X Lu; S Shinmei; H Badie-Mahdavi; T Bartfai
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

8.  Antiamnesic action of cromakalim, a potassium channel opener, in mice treated with hypoxia- and cerebral ischemia-type stress stimuli.

Authors:  K Nakao; S Tokuyama; M Takahashi; H Kaneto; H Ueda
Journal:  Cell Mol Neurobiol       Date:  1998-08       Impact factor: 5.046

9.  Intraganglionic laminar endings and their relationships with neuronal and glial structures of myenteric ganglia in the esophagus of rat and mouse.

Authors:  M Raab; W L Neuhuber
Journal:  Histochem Cell Biol       Date:  2004-09-18       Impact factor: 4.304

10.  Activation of ATP-sensitive K+ (K(ATP)) channels by H2O2 underlies glutamate-dependent inhibition of striatal dopamine release.

Authors:  Marat V Avshalumov; Margaret E Rice
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.